natal Marijuana and Public Health: The Colorado Perspective

Similar documents
natal Legal Marijuana: Medicine, Recreation or Plant?

Marijuana and CDPHE. Tista Ghosh, MD, MPH Deputy Chief Medical Officer

Hashing Out the Issues: Health and Safety in the Marijuana Industry Marijuana and Public Health

Blazing the Trail in Colorado Marijuana and Public Health. Tista Ghosh, MD, MPH

Marijuana Use During Pregnancy and Breastfeeding Findings Summary

Lessons Learned. Marijuana Education & Prevention in Colorado

PATIENT INTAKE FORM. Name: Address: Town: State: Zip Code: MMJ Card #: Exp. Date: Drivers License #: Exp. Date: Home Phone: Cell:

Blazing the Trail in Colorado Marijuana and Public Health

Barbara Brohl Executive Director & State Licensing Authority Colorado Department of Revenue

LEGAL ASPECTS of MEDICAL MARIJUANA Florida Nurse Practitioner Network Annual Conference September 17, 2018

Medical Marijuana Consent Form

INITIAL PATIENT INTAKE FORM

ASSEMBLY APPROPRIATIONS COMMITTEE STATEMENT TO. ASSEMBLY COMMITTEE SUBSTITUTE FOR ASSEMBLY, No STATE OF NEW JERSEY DATED: APRIL 5, 2018

Medical Marijuana Update

MINNESOTA S MEDICAL CANNABIS PROGRAM

PLENARY PANEL THE INTERSECTION OF MENTAL HEALTH AND MARIJUANA LEGALIZATION

PEDIATRIC EXPOSURE PREVENTION CLINICAL GUIDANCE FOR COLORADO HEALTH CARE PROVIDERS

Frequently Asked Questions

Marijuana and the Chronic Non-Cancer Pain Patient

PEDIATRIC EXPOSURE PREVENTION

MEMORANDUM. DATE: November 19, Senator Kohl-Welles. Kathleen Buchli, Counsel medical marijuana proposal

Minnesota. Prescribing and Dispensing Profile. Research current through November 2015.

OREGON MEDICAL MARIJUANA ACT

PATIENT QUESTIONNAIRE

79th OREGON LEGISLATIVE ASSEMBLY Regular Session. Senate Bill 1015 SUMMARY

NAVIGATING INDUSTRIAL HEMP REGULATIONS IN COLORADO. Thuy Vu Thuy Vu Consulting, LLC 2018 Rocky Mountain Food Safety Conference May 9, 2018

Cannabis Use: Scope of the Issue

The Department must establish a minimum of three regions within the state for the purpose of granting permits to growers/processors and dispensaries.

Substitute HB 523 Outline

78th OREGON LEGISLATIVE ASSEMBLY Regular Session. Senate Bill 964 SUMMARY

Senator Mark B. Madsen proposes the following substitute bill:

Changing the Drug Enforcement Administration (DEA) Schedule of Tetrahydrocannabinol (THC), Cannabidiol and Combinations to Promote Research

Julia Dilley, PhD Oregon Health Authority, Public Health Division & Multnomah County Health Dept.

CDHA 2016 Fall Symposium. Speaker Handout Files. For registered attendees only

Oregon Medical Marijuana Dispensary Program. Thomas A. Burns Director Pharmacy Programs Oregon Health Authority

House Economic Development Committee Medical Cannabis Overview

Effects of Prenatal Illicit Drug. Use on Infant and Child

Medical Cannabis Program. Dr. Maureen Small Co Medical Director Andrea Sundberg Program Coordinator

Outcome. Educating Ohio Providers On The Basics Related To Recommending Medical Marijuana. Connie J. Cerilli, APRN, FNP-C

Educating Ohio Providers On The Basics Related To Recommending Medical Marijuana. Connie J. Cerilli, APRN, FNP-C

Pennsylvania s Medical Marijuana Program

Cannabis Labeling Requirements By State

Cannabis and What we Know. Bonnie Schnittker RN PHN Public Health Nurse October 20, 2017

Coordinated Student Health Services. Medical Marijuana/ Low THC Cannabis Use To Qualified Students In Schools Policy

Oregon Retail Marijuana. Interim Update 7/7/15

Minnesota Medical Cannabis Program. October 24, 2017

Marijuana and Adolescent Brain Development

Cannabis Regulation. Costs If You Do Costs If You Don t. CSG 2017 National Conference. Andrew Freedman Freedman & Koski, Inc

2017 Legislative Update Marijuana Regulation. MACC Meeting May 26, 2017

Scottsdale Certification Center Health History Questionnaire. Name Gender M / F Date. Date of Birth / / Phone Ht: ft in Wt. Residential Address

Comprehensive Substance Abuse Strategic Action Plan

Marijuana Enforcement Division Consumer Safety Presentation. Kyle Lambert Deputy Director Analysis & Planning Section

Torri Metz, MD Maternal-Fetal Medicine December 15, 2017

Marijuana Education in a Post-Legalization Society Presented on October 31, 2017

INITIAL PATIENT INTAKE FORM

FY2019 Labor, Health and Human Services, Education Appropriations Summary

This questionnaire will ask you about approved medical use of extracts and tinctures of cannabis at national level.

SUPPLEMENTAL NOTE ON HOUSE BILL NO. 2031

Medical Cannabis MATT WEBSTER DO, MS

FY2018 Labor, Health and Human Services, Education Appropriations Summary

MARKET SIZE AND DEMAND 2017 MARKET UPDATE FOR MARIJUANA IN COLORADO. Prepared for the Colorado Department of Revenue

Clinical Education Initiative MEDICAL MARIJUANA 101. Speaker: Patricia Reed, PharmD

A Snapshot: Medical Marijuana in Rural New Mexico & Benefits of Legalizing Adult Use of Marijuana in Rural New Mexico

Suicide Prevention Strategic Plan

Ohio s Medical Marijuana Control Program

9/28/2015. Support. R01CA A1 Intervening with smoking parents of inpatients to reduce

Drug Overdose Morbidity and Mortality in Kentucky,

Cannabis Legalization and Regulation

Does Legality equal Legitimacy? The challenges of fostering safe practice with state legalization of marijuana

Questionnaire 1 of 5: Cannabis Plant and Cannabis Resin. Introduction

Second Regular Session Seventieth General Assembly STATE OF COLORADO INTRODUCED

Performance of North Carolina's System for Monitoring Prescription Drug Abuse. Session Law , Section 12F.16.(q)

Substance-Exposed Newborns

Weeding Through the Workplace Impact of Medical Marijuana

RESOLUTION NO A RESOLUTION APPROVING REFERRAL TO THE ELECTORS OF THE CITY OF ALBANY THE

Policy \ \ Medical (Palliative) Use of Marijuana

Medical Cannabis. Danial Schecter, MD, CCFP. Vocational Rehabilitation Association November 7th, Executive Director Cannabinoid Medical Clinic

Medicinal cannabis. What is medicinal cannabis? What are cannabinoids? The endocannabinoid system

Compassionate Medical Cannabis: What It Means to the Street Officer

Pennsylvania s Medical Marijuana Program

POLICY NUMBER: POL 153

New Mexico. Prescribing and Dispensing Profile. Research current through November 2015.

Denver s Regulation of Hemp Products

Acknowledgements: What it is What it s not. Cannabis Evidence Series. Evidence-informed decision-making

MARIJUANA LEGALIZATION

Substance-Exposed Newborns

Statewide Services for Traumatic Brain Injuries, Alzheimer s Disease, and Dementia

420 ADVISORY MANAGEMENT

CERTIFICATION OF ENROLLMENT ENGROSSED SUBSTITUTE SENATE BILL th Legislature 2007 Regular Session

Revenue Impact of CS/CS/SB 1030 (2014 Legislative Session) Updated Revenue impact of CS/CS/SB 1030 (2014 Legislative Session)

77th OREGON LEGISLATIVE ASSEMBLY Regular Session. Enrolled. House Bill 3460

MEMORANDUM INTRODUCTION. DATE: July 28, 2016; Revised August 3, 2016 TO:

North Central Florida Regional Planning Council

Rhode Island. Prescribing and Dispensing Profile. Research current through November 2015.

Medical Marijuana Legalization and the Impact on Colorado s Counties. CCAP Workshop

Q & A With MPP s Rob Kampia Regarding the 2016 Ohio Medical Marijuana Initiative

An Overview of the Government of Canada s Approach to Legalize, Regulate and Restrict Access to Cannabis

EXAMPLE OF STORE FRONT

2018 Training Opportunities

Appendix C NEWBORN HEARING SCREENING PROJECT

Transcription:

natal Marijuana and Public Health: The Colorado Perspective Larry Wolk, MD MSPH Executive Director and CMO September 2015 1

natal 2

natal CDPHE Role Medical Marijuana Registry Medical Marijuana Research Retail Marijuana Education Marijuana Surveillance Laboratory Certification 3

Medical Marijuana Registry 2

Medical Marijuana Registry Role Issue Medical Marijuana Registry cards Maintain database of registered patients Review petitions for adding debilitating medical conditions to the medical use of marijuana regulations Administer grant programs for clinical and observational research related to potential therapeutic uses of marijuana 5

The Registration Process Step 1: Patient is examined by a Colorado licensed M.D. or D.O. in good standing, After examination. Physician completes Physician Certification Form with plant/oz recommendation Step 2: Patient completes the application for registration card and signs it in front of a notary. Caregiver acknowledgement completed, if one is designated. Step 3: Submit application by certified mail for proof of mailing. Step 4: Paperwork is evaluated. Step 4-Approved Step 4- Rejected: Referred to payment processing and notice of rejection is sent to patient. Complete App Includes: Application Physician certification dated within 60 days. $15 application fee or fee waiver. Copy of valid CO ID or waiver documentation Step 5: All funds received by the Registry are nonrefundable. Check or money order are made payable to CDPHE. Cash is not advised. Credit cards are not accepted at this time. Step 6: Cards are printed once an application is approved and payment has been processed. Cards are mailed standard first class mail to the address on the application. Processing Time: Patients are encouraged to allow 45 60 days for the entire process, including physician exam. It takes no longer than 35 days for an application to be processed once received 6

Current Registry Statistics As of June 2015 Current Status of Registry 301,677 total patients have applied for a registration card since 2001 113,585 active patients are currently on the Registry 1,579 physicians have recommended medical marijuana since 2001 800 physicians have recommended medical marijuana to one or more patients in the last year 16.4% of active patients have an increased plant count Note: Statistics change frequently based upon patient change requests and are updated on our website on a monthly basis. https://www.colorado.gov/pacific/cdphe/statistics-and-data

Current Registry Statistics As of June 2015 Current Status of Registry 32,049 active patients have designated a medical marijuana center 4,609 active patients have designated a caregiver 6,523 active patients have an increased plant count AND have designated a caregiver or medical marijuana center The Registry currently has 22 FTE The Registry processes an average of 15,000 pieces of mail per month Note: Statistics change frequently based upon patient change requests and are updated on our website on a monthly basis https://www.colorado.gov/pacific/cdphe/statistics-and-data

Medical Marijuana Research 9

Summary of Evidence re: Medical Benefits Cannabis has some fairly well documented medical benefits: Chronic neuropathic pain Multiple sclerosis Chemotherapy induced nausea & vomiting Wasting syndrome (cachexia) with AIDS Clear need for clinical trials for most of the conditions for which cannabis already officially accepted as effective, as well as for many other conditions of interest: PTSD Epilepsy Inflammatory bowel disease Cancer Other neurologic and psychiatric conditions Opiate dependence and withdrawal 10

Medical Marijuana Research Grant Program Senate Bill 14-155, Concerning Grant Funding for Medical Marijuana Health Effects Studies Legislative Intent: that the Department gather objective scientific research regarding the efficacy of administering marijuana and its component parts as part of medical treatment. The grant program shall fund observational trials and clinical trials. In order to ensure objectivity in evaluating research proposals, the grant program shall establish a scientific advisory council. $10 million over 5 years from medical marijuana cash fund 11

Grants Approved by Board of Health 1. Observational study of MJ for IBD in adolescents/young adults 2. Observational study of MJ for PTSD 3. Observational pharmacokinetic study of high CBD oils for pediatric epilepsy 4. Observational study of high CBD oils for pediatric epilepsy 5. Observational study of quality of life from using MJ in children with CNS tumors 6. Observational study of MJ for sleep disorders 7. RCT of MJ (4 potencies THC & CBD) for PTSD in veterans 8. RCT of CBD for tremor in Parkinson s Disease 9. RCT of MJ versus oxycodone for chronic spine pain 12

Retail Marijuana Education 13

Retail Marijuana Prevention and Education Campaign (SB 14-215) Ensure that all Colorado residents and visitors understand the parameters of safe, legal and responsible use of retail marijuana. 14

Prevention and Education Campaign (SB 14-215) 1. 18-month campaign: health effects of marijuana & parameters of legal use 15

Prevention and Education Campaign (SB 14-215) 2. Ongoing education and prevention campaign: Retailer (tourists at point of sale) Latino/Hispanic Audience Youth Prevention Fact Sheets 16

Prevention and Education Campaign (SB 14-215) 3. Maintenance of website portal: colorado.gov/marijuana 4. Alignment of messaging across state agencies Addressing agency concerns Partnering with other state agencies to provide resources and training to complement prevention work 17

Prevention and Education Campaign (SB 14-215) 5. Evaluation of the campaigns Baseline statewide, targeted-population surveys complete Follow-up statewide survey following Good to Know campaign currently in the field Annual assessments each year to monitor change Will review data from other sources to monitor trends 18

Monitoring Potential Health Effects and Changes in Use Patterns 19

CDPHE and Retail Marijuana (C.R.S. 25-1.5-111 & SB-13-283) Surveillance Role SB 13-283 "Monitor changes in drug use patterns, broken down by county and race and ethnicity, and the emerging science and medical information relevant to the health effects associated with marijuana use. 20

Retail Marijuana Public Health Advisory Committee (SB 13-283) The Department shall appoint a panel of health care professionals with expertise in cannabinoid physiology to monitor the relevant information. The panel shall: Provide a report by 1/31/15 and every 2 years thereafter Establish criteria for 1) studies to be reviewed, and 2) reviewing studies and other data, and Make recommendations, as appropriate, for policies intended to protect consumers of marijuana or marijuana products and the general public. 21

Duties of Advisory Committee Systematically review the scientific literature Come to consensus on population health effects of marijuana use Develop public health statements Come to consensus on translation of the science into simplified language Recommend public health related policies Recommend public health surveillance activities Identify research gaps important to public health 22

Marijuana Use Among Adolescents Substantial Moderate Limited Mixed Other illicit drug use and addiction after adolescence Impaired cognitive abilities and academic performance after 28 days abstinence Lower IQ after short abstinence Anxiety after adolescence Psychotic symptoms or disorders like schizophrenia Less high school graduation Less likely to earn college degree Depression after adolescence Increased MJ use and addiction after adolescence Suicidal thoughts or attempts Alcohol or tobacco use and addiction after adolescence Quitting lowers risk of cognitive and mental health effects

Target Pop. Problem Monitoring Young Children Accidental Poisoning UC/Childrens Research Project Colorado Hospital Association (CHA) Data Rocky Mountain Poison and Drug Center Calls Child Health Survey(CHS) - risk factors Youth Surveillance Activities Increased Use/Abuse Healthy Kids Colorado Survey (aka YRBS) Adults Pregnant/ Breastfeeding Poisoning, Overdose, Abuse Accidents/Trauma Increased Use/Abuse Poisoning, Overdose, Abuse Accidents/Trauma Contaminated Products Birth Defects, Developmental Disabilities Colorado Hospitalization Data Rocky Mountain Poison and Drug Center Calls Colorado Hospitalization Data Colorado Trauma Registry Behavioral Risk Factor Surveillance System (BRFSS) Influential Factors for Healthy Living Survey (TABS) Colorado Hospitalization Data Rocky Mountain Poison and Drug Center Calls Colorado Hospitalization Data & Trauma Registry Pilot Surveillance (Ski-Related Injuries) Food-borne Illness Surveillance related to Edibles Rocky Mountain Poison and Drug Center Calls Pregnancy Risk Assessment Monitoring System (PRAMS) Active Surveillance (Birth Defects Registry) 24

Healthy Kids Colorado Survey

Rates of Hospitalizations (HD) and Emergency Department (ED) Visits with Possible Marijuana Exposures, Diagnoses, or Billing Codes in the First Three Diagnosis Codes per 100,000 HD and ED Visits by Time Period in Colorado. * * * NA NA N b =1,211 N=12,328 N=16,428 N=7,080 N=5,014 N=1,191 Prior Legalization of Medical Marijuana Medical Marijuana Legalized Medical Marijuana Commercialized Retail Marijuana Legalized

Retail Marijuana Testing Facility Inspection Program 27

Retail marijuana testing facility inspection program: Coordinates inspection of retail marijuana testing facilities; Reviews all documentation and practices relating to laboratory methods, staff qualifications, and quality assurance; Ensures that testing facilities meet the rules promulgated by the Department of Revenue (DOR) and are competent to carry out specific scientific tests; Provides recommendations to DOR about suitability of the testing facilities for certification; and, Provides scientific consultation and recommendations to the DOR in regards to laboratory testing as it pertains to public health and safety. 22

As of May 26, 2015, nineteen Retail Marijuana Testing Facilities have been licensed by DOR. Eleven of those have been granted provisional certifications. Testing Category Potency Microbials (Bacteria, Fungus) Residual Solvents Number of Labs Currently Certified 10 3 6 *Inspections are ongoing 23

natal 30

Questions? 24